As of 2025-07-09, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (22.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.92 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -326.8%.
The range of the Relative Valuation is (21.56) - (22.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.5x - 18.4x | 18.0x |
| Forward P/E multiples | 17.8x - 20.5x | 19.2x |
| Fair Price | (21.56) - (22.23) | (22.50) |
| Upside | -317.3% - -324.1% | -326.8% |
| Date | P/E |
| 2025-07-03 | -7.95 |
| 2025-07-02 | -7.82 |
| 2025-07-01 | -7.52 |
| 2025-06-30 | -7.67 |
| 2025-06-27 | -7.62 |
| 2025-06-26 | -7.82 |
| 2025-06-25 | -7.60 |
| 2025-06-24 | -7.51 |
| 2025-06-23 | -6.92 |
| 2025-06-20 | -6.72 |
| 2025-06-18 | -6.89 |
| 2025-06-17 | -6.86 |
| 2025-06-16 | -7.23 |
| 2025-06-13 | -7.22 |
| 2025-06-12 | -7.40 |
| 2025-06-11 | -7.29 |
| 2025-06-10 | -7.37 |
| 2025-06-09 | -7.36 |
| 2025-06-06 | -7.46 |
| 2025-06-05 | -6.99 |
| 2025-06-04 | -6.93 |
| 2025-06-03 | -6.89 |
| 2025-06-02 | -6.70 |
| 2025-05-30 | -6.62 |
| 2025-05-29 | -6.73 |
| 2025-05-28 | -6.52 |
| 2025-05-27 | -5.74 |
| 2025-05-23 | -6.03 |
| 2025-05-22 | -5.96 |
| 2025-05-21 | -6.03 |
| 2025-05-20 | -6.28 |
| 2025-05-19 | -6.21 |
| 2025-05-16 | -5.97 |
| 2025-05-15 | -5.93 |
| 2025-05-14 | -5.73 |
| 2025-05-13 | -5.79 |
| 2025-05-12 | -6.11 |
| 2025-05-09 | -5.84 |
| 2025-05-08 | -6.16 |
| 2025-05-07 | -5.83 |
| 2025-05-06 | -5.93 |
| 2025-05-05 | -6.39 |
| 2025-05-02 | -7.27 |
| 2025-05-01 | -7.05 |
| 2025-04-30 | -6.86 |
| 2025-04-29 | -6.79 |
| 2025-04-28 | -6.72 |
| 2025-04-25 | -6.37 |
| 2025-04-24 | -6.53 |
| 2025-04-23 | -6.49 |